Bristol-Myers Squibb Company(BMY)
NASDAQ

Stock Price Forecast & Analyst Targets

$60.74
0.23 (0.38%)

BMY Stock Forecast Chart

BMY Stock Forecast 2026 – Price Prediction, Target & Outlook

Bristol-Myers Squibb Company (BMY) stock forecast for 2026 indicates a wide range of potential outcomes based on analyst targets and model-driven predictions. As of July 2026, BMY stock shows a dynamic price pattern in the short term, with price targets reflecting potential future volatility across bull, base, and bear scenarios over the next 12 months.

BMY Bull Case Price Target (2027)

$80.78

In a bullish scenario, BMY stock could reach this maximum projection over the next 12 months, driven by upside momentum and outperforming technical indicators.

BMY Base Forecast (2027)

$60.78

The base case model predicts this median target, assuming BMY maintains steady growth, consistent volume profiles, and normalized market conditions.

BMY Bear Case Price Target (2027)

$40.79

In a broader market downturn or bearish correction, BMY shares could potentially trace back to this support level over the forecast horizon.

Confidence:60.3% (Moderate)
Signal:Short-Term Bullish
6M + 12M
Historical
Forecast Avg
Max Range
Min Range
Prophet Model Forecast

Bristol-Myers Squibb Company Analyst Consensus & Target Price

Wall Street sentiment and price target analysis for BMY

HOLD

Consensus based on 25 analysts

Neutral outlook - price at fair value

Mean Target Price
$63.08+3.9%
High Target$75.00
Low Target$40.00
Number of Opinions25

Price Target Analysis

Target Range: $40.00 - $75.00

Current vs Mean Target: +3.9%

Analyst Coverage: 25 firms tracking

Key Considerations

• Target prices reflect 12-month outlook

• Based on fundamental analysis and DCF models

• Consider market volatility in timing decisions

BMY stock Price Projections & Forecast Models

Data-driven price predictions based on technical analysis and analyst consensus for BMY

Model-Based Predictions

$60.74
1-Month Target
+0.0%
$60.78
1-Year Target
+0.1%

Analyst Consensus

$63.08
Analyst Mean Target
+3.9% vs Current

Model Methodology & Confidence

Technical Indicators:

  • • Moving averages (SMA 20, 50, 200)
  • • RSI and momentum oscillators
  • • Support/resistance levels
  • • Volume-price analysis

Fundamental Factors:

  • • Earnings growth projections
  • • Revenue trend analysis
  • • Valuation multiple normalization
  • • Sector performance correlation

Scenario Analysis Chart

Bristol-Myers Squibb Company (BMY) Detailed Price Forecast

Algorithmic projections for monthly price bands and momentum signals

According to current predictive modeling and historical volatility analysis, the company is projected to fluctuate between a potential low of $40.79 and a high of $80.78 over the forecast horizon. These estimates blend near-term technical momentum with fundamental analyst consensus targets.

PeriodMin PriceAvg PriceMax PricePotential ROISignal
Aug 202654.9860.7466.51+0.0%
Hold
Sep 202652.5960.7568.90+0.0%
Hold
Oct 202650.7660.7570.74+0.0%
Hold
Nov 202649.2260.7572.29+0.0%
Hold
Dec 202647.8660.7673.66+0.0%
Hold
Jan 202746.6360.7674.89+0.0%
Hold
Feb 202745.5060.7776.03+0.0%
Hold
Mar 202744.4560.7777.09+0.0%
Hold
Apr 202743.4660.7778.08+0.1%
Hold
May 202742.5360.7879.03+0.1%
Hold
Jun 202741.6460.7879.92+0.1%
Hold
Jul 202740.7960.7880.78+0.1%
Hold

Source methodology: Model forecasts are independent estimates blending technical signals with analyst consensus data. Actual market prices are subject to volatility and macroeconomic factors. All projections are for informational purposes only.